Literature DB >> 23035593

Functional RNA delivery targeted to dendritic cells by synthetic nanoparticles.

Kenneth C McCullough1, Isabelle Bassi, Thomas Démoulins, Lisa J Thomann-Harwood, Nicolas Ruggli.   

Abstract

Dendritic cells (DCs) are essential to many aspects of immune defense development and regulation. They provide important targets for prophylactic and therapeutic delivery. While protein delivery has had considerable success, RNA delivery is still expanding. Delivering RNA molecules for RNAi has shown particular success and there are reports on successful delivery of mRNA. Central, therein, is the application of cationic entities. Following endocytosis of the delivery vehicle for the RNA, cationic entities should promote vesicular membrane perturbation, facilitating cytosolic release. The present review explains the diversity of DC function in immune response development and control. Promotion of delivered RNA cytosolic release is discussed, relating to immunoprophylactic and therapeutic potential, and DC endocytic machinery is reviewed, showing how DC endocytic pathways influence the handling of internalized material. The potential advantages for application of replicating RNA are presented and discussed, in consideration of their value and development in the near future.

Mesh:

Substances:

Year:  2012        PMID: 23035593     DOI: 10.4155/tde.12.90

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  7 in total

1.  Glycan-binding profile of DC-like cells.

Authors:  Eugenia M Rapoport; Ekaterina V Moiseeva; Dmitry A Aronov; Sergey V Khaidukov; Galina V Pazynina; Svetlana V Tsygankova; Ivan M Ryzhov; Ivan M Belyanchikov; Tatiana V Tyrtysh; Kenneth C McCullough; Nicolai V Bovin
Journal:  Glycoconj J       Date:  2019-12-13       Impact factor: 2.916

Review 2.  Modeling Influenza Virus Infection: A Roadmap for Influenza Research.

Authors:  Alessandro Boianelli; Van Kinh Nguyen; Thomas Ebensen; Kai Schulze; Esther Wilk; Niharika Sharma; Sabine Stegemann-Koniszewski; Dunja Bruder; Franklin R Toapanta; Carlos A Guzmán; Michael Meyer-Hermann; Esteban A Hernandez-Vargas
Journal:  Viruses       Date:  2015-10-12       Impact factor: 5.048

3.  Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids.

Authors:  Pavlos C Englezou; Cedric Sapet; Thomas Démoulins; Panagiota Milona; Thomas Ebensen; Kai Schulze; Carlos-Alberto Guzman; Florent Poulhes; Olivier Zelphati; Nicolas Ruggli; Kenneth C McCullough
Journal:  Mol Ther Nucleic Acids       Date:  2018-05-04       Impact factor: 8.886

4.  Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine.

Authors:  Federico Perche; Rudy Clemençon; Kai Schulze; Thomas Ebensen; Carlos A Guzmán; Chantal Pichon
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-30       Impact factor: 8.886

5.  Self-Amplifying Pestivirus Replicon RNA Encoding Influenza Virus Nucleoprotein and Hemagglutinin Promote Humoral and Cellular Immune Responses in Pigs.

Authors:  Thomas Démoulins; Nicolas Ruggli; Markus Gerber; Lisa J Thomann-Harwood; Thomas Ebensen; Kai Schulze; Carlos A Guzmán; Kenneth C McCullough
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

Review 6.  Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles.

Authors:  Kenneth C McCullough; Panagiota Milona; Lisa Thomann-Harwood; Thomas Démoulins; Pavlos Englezou; Rolf Suter; Nicolas Ruggli
Journal:  Vaccines (Basel)       Date:  2014-10-16

7.  Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo.

Authors:  Kenneth C McCullough; Isabelle Bassi; Panagiota Milona; Rolf Suter; Lisa Thomann-Harwood; Pavlos Englezou; Thomas Démoulins; Nicolas Ruggli
Journal:  Mol Ther Nucleic Acids       Date:  2014-07-08       Impact factor: 10.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.